Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
Müjdat Zeybel, Özlem Altay, Muhammad Arif, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 10
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yuluğ, Özlem Altay, Xiangyu Li, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
Müjdat Zeybel, Muhammad Arif, Xiangyu Li, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 42
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Genome-scale models in human metabologenomics
Adil Mardinoğlu, Bernhard Ø. Palsson
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 9
Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease
Retu Haikonen, Olli Kärkkäinen, Ville Koistinen, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 7, pp. 463-480
Open Access | Times Cited: 31
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Angelique Cercillieux, Eleonora Ciarlo, Carles Cantó
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 30
The acute effect of different NAD+ precursors included in the combined metabolic activators
Xiangyu Li, Hong Yang, Han Jin, et al.
Free Radical Biology and Medicine (2023) Vol. 205, pp. 77-89
Closed Access | Times Cited: 13
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
Fateme Ziamanesh, Mehdi Mohammadi, Sholeh Ebrahimpour, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 1083-1094
Open Access | Times Cited: 13
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
Özlem Altay, Hong Yang, Serkan Yıldırım, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 927-927
Open Access | Times Cited: 4
Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment
Neda Mohaghegh, Amir Ahari, Claire Buttles, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4
Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
Sergio Quesada‐Vázquez, Caitlin Bone, Shikha Saha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13675-13675
Open Access | Times Cited: 19
Alterations of the Gut Microbiome in Patients With Pituitary Adenoma
Jinxian Hu, Jihu Yang, Lei Chen, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 14
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Xi Jia, Erfei Song, Yan Liu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101257-101257
Open Access | Times Cited: 8
Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
Anoop T. Ambikan, Sara Svensson Akusjärvi, Shuba Krishnan, et al.
Life Science Alliance (2022) Vol. 5, Iss. 9, pp. e202201405-e202201405
Open Access | Times Cited: 11
Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet
Hong Yang, Jordi Mayneris‐Perxachs, Noemí Boqué, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1440-1440
Open Access | Times Cited: 12
Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators
Hong Yang, Xiangyu Li, Han Jin, et al.
Free Radical Biology and Medicine (2023) Vol. 204, pp. 347-358
Open Access | Times Cited: 4
Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients
Susanne Csader, Xiuqiang Chen, Howell Leung, et al.
mSystems (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 4
A cocktail of histidine, carnosine, cysteine and serine reduces adiposity and improves metabolic health and adipose tissue immunometabolic function in ovariectomized rats
Julio Baudin, Julia Hernández-Baixauli, Jordi Romero‐Giménez, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117326-117326
Open Access | Times Cited: 1
Revisiting the role of serine metabolism in hepatic lipogenesis
Hong Yang, Cheng Zhang, Hasan Türkez, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 760-761
Closed Access | Times Cited: 3
Pharmacological and Nutritional Modulation of Metabolome and Metagenome in Cardiometabolic Disorders
Anna Maria Witkowska, Joe‐Elie Salem
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1340-1340
Open Access | Times Cited: 2
Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD
Kelly D. McCall, Debra Walter, Ashley Patton, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5339-5366
Open Access | Times Cited: 2
Tryptophan metabolism and liver fibrosis
Hui-Xing Wu, Changrui Long, Zhenhua Zhang, et al.
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 3, pp. 192-198
Open Access
Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention
Atakan Burak Ceyhan, Ali Kaynar, Özlem Altay, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1376-1376
Open Access
Page 1 - Next Page

Scroll to top